The International Society of Dacryology and Dry Eye (ISD-DE) XIVth Congress
29th – 31st May 2024, County Hall, Belvedere Road, London SE17PB, UK
Our main sponsors
Our sponsors can be seen at the bottom of this page
A report on the ISD-DE Congress Wednesday May 29th through to Friday May 31st .
We thank our sponsors and you can read their stories behind their attendance at the Congress, the largest 3 day Dry and Watery Eye extravaganza in the UK this year, Over 100 speakers attended.
Read what each sponsor will be exhibiting at the congress at the bottom of this page .
Please scroll down
Reports on ISD-DE Congress held last week in London
Cornea Meets Plastics, ISD-DE Meeting London
The Joy of ISD-DE was the contact between Corneal Ophthalmologists and Oculoplastic Surgeons, Optometrists and Patient Advisor Support Groups.
The International Society of Dacryology and Dry Eye (ISD-DE) 2024 Update course and Scientific Meeting May 29th, 30th and 31st, was held at the emblematic County Hall.
A report by:
Jane Olver, President ISD-DE and London 2024 meeting Organiser
The ISD-DE proved the perfect place for corneal and oculoplastic ophthalmologists. We were able to mingle, network and exchange ideas in relaxed surroundings overlooking the Thames and Big Ben, touch base on common ground and grow from each other’s knowledge. Our common ground was watery and dry eyes, which often co-exist in the same patient.
Examples of the dry eye lecturers below. My sincerest thanks to all of them for making this a wonderful and memorable meeting, I love you all my Corneal, Plastics and Optometry Colleagues!
Johnson Yan Ning Neo spoke on Challenging Corneal Ocular Surface, Daphna Landau, MD on Eyelid Surgery and Dry Eye, Sajjad Ahmad on Meibomian Gland Dysfunction (MGD), Siobhan Wren on Advanced Options for Dry Eyes, Raman Malhotra on Eyelid causes of Dry Eyes, Francesco Quaranta Leoni on the Management of POst Operative Tearing, Laura Maubon on basic Assessment Dry Eyes, Nizar Din on Basic Treatments of Dry Eyes, Tristan McMullan on Eyelid causes of Watering Eyes. Robert Scott spoke on Corneal Trauma and Dry Eyes – Which Drops?
We were delighted to have Dr Wolfgang GK Müller-Lierheim from Germany explain to us his Hypothesis that Hyaluronan is a Key Player in the Maintenance of the Ocular Surface Integrity.
Hormones play a role in Dry Eyes but this is not always clear. Dr Theadora Kalentzi who runs the Menopause Clinic in the City spoke all about Dry Eyes and the Menopause.
Professor Harminder Dua (right) from Nottingham gave two lectures including the Inaugural Schirmer Lecture on Ocular Surface reconstruction: Principles and procedures, as well as his lecture The tear Film in Ocular Defence.
There was also Sai Kolli, Daniel Ezra, Nikolina Budimlija, Vickie Lee, Jonathan Roos, Rachna Murthy with lectures and workshops on Lifestyle and Dry Eyes, and Melanie Corbett on the Cryptic Culprit in Ocular Surface disease – namely cosmetics that seep onto the ocular surface.
Advice: Use less makeup and facial cosmetics. But don´t forget to use the very light SPF50 sunscreen, not too near the eyes, to protect your skin from ageing and sun-damage, risk skin malignancy. Basically, the heat of the face melts the face creams and they spread across the face and get into the eyes. Other tip was to always wash your hands after putting any cosmetics on your face as we are always touching our eyes and can deliver chemicals directly that way, which can reach the ocular surface and cause inflammation.
Lastly but certainly not least, Optometrist Super Star Brian Tompkins (left) and his Edutainment – Sclerals Rock! Optometry & Dry Eye Management Success, along with rock music and distinctive educative style.
SM: #IntSocDryEye,#Cornea,#Oculoplastic,#Plastics,#Lacrimal,#ClinicaLondon,#Dryeyes,#Wateryeyes,#JaneOlver
Article written by Ms Jane Olver, FRCS FRCOpht, President ISD-DE and 2024 London Meeting Organiser, owner and Medical Director, Consultant Oculoplastic Surgeon Clinica London.
WATCH THIS SPACE – NEXT ISD-DE CONGRESS
The XVth Congress of ISD-DE will be held in June 2026, in Tallinn, Estonia, to be organised by Dr Kadi Palumaa
The ISD-DE Preview pages archived for a further 2 weeks
Whilst we receive updates from our Sponsors
Clinica London and Academy are delighted to have been the Platinum Sponsors of the XIVth Congress of the International Society Dacryology and Dry Eye, London, May 29th to 31st 2024, held at London´s County Hall, opposite the emblematic Big Ben. We hope all the Sponsors, speakers and delegates enjoyed the meeting and have taken home good memories, made new friends, as well as been inspired by the educational content!
Clinica London, with the Clinica London Academy, Clinicas´ Educational Division, support, promote, and generate dissemination of innovation and critical medical developments in Ophthalmology. We specifically chose to support the field of watery and dry eyes as the Platinum Sponsor of ISD-DE 2024. We are proud of ISD-DE and it´s area of technical advancement, inspiration and communication of knowledge, of the cultural exchange it offers.
Thank you to all the Clinica London Staff for giving up 4 days of their Clinica London duties 28th – 31st May to prepare and run the Reception, and for doing the back ground organising for many months preceding this meeting!
Clinica London and the Clinica London Academy are proud to lead the way and inspire though educational events, and in supporting ISD-DE as the only Platinum Sponsor. We believe strongly in collaboration and education, between ophthalmic colleagues, optometrists, allied health care professionals and our patients. @clinicalondon.co.uk
ISD-DE is unique in its broad base and inclusive philosophy. @isd-de.org It is an International Society and it was an honour to support the XIVth Congress.
The next meeting will be in June 2026, in Tallinn, Estonia.
More about Clinica London
Clinica London is a Privately run Ophthalmology and Dermatology Clinic Eyes, Aesthetic and Skin in London´s Harley Street Medical Area. Our Consultants have a heightened awareness of the enormous burden of dry eye disease and lacrimal outflow stenosis affecting both children and adults. We know that watery and dry eyes are increasingly common symptoms, often made worse by triggers such as cosmetics, long screen use, stress, allergens, pollution, air conditioning and central heating, contact lens and much more. Patient ocular comfort, clarity of vision and non-watery eyes is the “Holy Grail” by ophthalmologists in the field of cornea and oculoplastics.
Thanks to our Sponsors
Here is a preview from our major sponsors information :
Clinica London Platinum Sponsor
FCI (A Zeiss Company) GOLD Sponsor
Santen Bronze Sponsor
Machida Bronze Sponsor
Thea Pharmaceuticals Limited Bronze Sponsor
Essilor/Luxottica Sponsor
Scope Sponsor
Topcon Healthcare Sponsor
Platinum Sponsors of the XIVth Congress of the International Society Dacryology and Dry Eye, London 2024
with
Clinica London Academy
Clinica London, with the Clinica London Academy, the Clinica Educational Division, supports, promotes and helps generate dissemination of innovation and critical medical developments in the field of watery and dry eyes.
We are proud of ISD-DE and it´s area of technical advancement, inspiration and communication of knowledge, the cultural exchange it offers. We look forwards to sharing interactions at this XIVth Congress ISD-DE.
Clinica London is an Ophthalmology and Dermatology Clinic Eyes, Aesthetic and Skin in London´s Harley Street Medical Area. Our Consultants in Ophthalmology and Dermatology have a heightened awareness of the enormous burden of dry eye disease and lacrimal outflow stenosis in 2024, affecting children and adults. Ocular comfort, clarity of vision and non- watery eyes is the “Holy Grail” we seek for our patients.
Clinica London Academy is proud to lead the way and inspire though its educational events and in supporting ISD-DE. We believe strongly in collaboration and education, between ophthalmic colleagues, optometrists, allied health care professionals and patients.
https://www.clinicalondon.co.uk/clinica-london-academy/
Find out more HERE
FCI
FCI is a world leader in the development of a wide range of ophthalmic devices.
Over the past four decades, FCI has been dedicated to providing physicians with innovative,
high-performance and mostly exclusive products covering the fields of expertise of Oculoplasty, Dry Eye, Retina and Cataract.
Your Patients, Our Expertise.
Our core business and activities involve extensive research & development and advanced manufacturing processes to enhance the effectiveness and performance of the procedures performed by our customers.
FCI is a global, multi-site company with its headquarter in Paris, France, a branch FCI Ophthalmics in Boston, MA (USA) managing our North American operations, and a strong distribution network that serves more than 80 countries.
Find out more HERE
SANTEN
At Santen, we have been dedicated to ophthalmology since 1899. We will always aspire to lead the ophthalmology field – we will not be distracted by other therapy areas or trends.
Physicians can trust that we have the utmost dedication to the highest standards of quality, safety and compliance. Santen is committed to improving the eye health of patients, using our global breadth of scientific innovation.
Santen is a leader and trusted partner in glaucoma treatment, having a full spectrum of products for patients of all stages, and has a growing portfolio particularly in dry eye disease (DED), retinal conditions and allergy.
We expand our reach and expertise through investing in meaningful partnerships with healthcare professionals, academia, institutions and innovator companies.
Find out more HERE
MACHIDA
Machida Endoscope is happy to introduce our 0.9/0.7mm dacryoscopes at the ISD-DE 2024, which provide visual information of patient’s lacrimal system to support your diagnosis, choice of treatment, and instrument handling before and during procedure.
Our dacryoscope is characterized by its gentle S-curve shape, brilliant image quality, and durability. The unique shape will help its smooth insertion to the sac and to the nasolacrimal duct. The clear image will precisely locate and reveal the conditions of the obstruction site. Despite of its fine diameter, its durability has been proven in clinical use in Japan.
MACHIDA Endoscope Co., Ltd. was founded as a manufacturer of medical endoscopes in 1956, which is one of few companies that can provide flexible fiber-optic endoscopes in the world at that time.
Over the past five decades, MACHIDA has developed a well-earned reputation for a number of accomplished technological achievements, and become one of the leading companies worldwide in the endoscopy industry.
MACHIDA has also emphasized its expansion into advanced industrial fields, such as industrial endoscopes, optical sensors and laser related equipment, and will continue to contribute its expertise to the development of both medical and industrial devices.
Please come visit our booth to experience the dacryoscopy. We have a lacrimal system anatomy model to play with.
Find out more HERE
Thea Pharmaceuticals Limited
Thea Pharmaceuticals Limited is an innovative company solely dedicated to developing high-quality products that support ophthalmic care and eye health across the UK and Ireland.
Our extensive range includes both prescription and non-prescription products that are free from preservatives.
We have prescription products for Glaucoma, Inflammation, Infection and Allergy, as well as a range of cutting edge Surgical Pharmaceuticals.
We also have non-prescription products to help alleviate Dry Eye, Blepharitis and Meibomian Gland Dysfunction, along with a range of Eye Nutritionals to generally support eye health and help to maintain vision.
EssilorLuxottica is looking forward to welcoming ECPs to its stand at the ISD-DE 2024 Congress on May 29th – 31st 2024 where it will be showcasing its portfolio of dry eye equipment.
During the event, delegates will discover key pieces of equipment available from EssilorLuxottica which when used together in practice, offer a complete solution for diagnosing dry eye and managing the condition.
Paul Cumber, instruments director at EssilorLuxottica, said: “Dry eye is most certainly a growing area of opportunity for opticians and setting up a dry eye clinic will help differentiate practices as well as helping patients to manage the condition.
“The return on investment is very quick and we support practices in pricing the service, and providing training for the team, as well as marketing support to promote and drive awareness.”
DRY EYE PORTFOLIO
IDRA by SBM Sistemi allows ECPs to accurately capture tear film instability data, and then provide clearly presented metrics that are simple for the patient to understand. It also has an accompanying smart phone app, which is an excellent way for patients to monitor their dry eye symptoms at home.
It performs a full assessment of the ocular surface via a series of quick tear film tests, including the quality of tears and analysis of the meibomian glands, to classify the type of dry eye disease.
Paul Cumber said: “The IDRA imaging system is a compact and cost-effective piece of kit which provides strong evidence to support your choice of treatment, while helping the patient understand why that therapy is being recommended.”
The TearStim IRPL device from ESW Vision emits energy in the form of painless light pulses and heat and is applied to the skin below the eye. The aim is to stimulate the parasympathetic nervous system supplying the meibomian glands, increase the secretion from the glands and contribute to restoring their normal activity. In addition, the quality of the secretion is improved, and the lipid layer of the tear film is stabilised.
Paul Cumber continues: “The effectiveness of IRPL treatments such as TearStim can be enhanced further by using the Activa Home Eye Mask which uses heat and massage to increase meibomian gland output, so eyes stay lubricated and symptom-free for longer.”
The Activa Home Eye Mask by SBM Sistemi uses heated automatic massage technology and patients can rent the device from the practice to use at home or more frequently it is offered as an in-practice treatment. The fully automated procedure heats and massages the eye lids generating heat of approximately 42 degrees for 15 minutes while applying a micro-vibration-based massage to aid meibomian gland expression.
Find out more HERE
Scope
Scope is a family-run company for three generations with a heritage of bringing evidence-based, premium products to healthcare professionals and end-consumers alike.
Scope offers innovative Ocular Surface Disease Management Dry Eye and Blepharitis products.
Scope operates in the United Kingdom, Ireland and now the USA Scope ensures its product offerings are well-established with a track record of successfully treating patients worldwide.
Find out more HERE
Topcon will be showcasing its dry eye solutions at ISD-DE 2024.
The ScoutPro from Trukera, recently added to our product portfolio. Hyperosmolarity is a causative factor that leads to abnormal slit lamp exam results, with 80% of cataract patients at risk for ocular surface disease, and 1in 5 cataract patients risk a >1D variation in keratometry measurements and the ScoutPro brings the power of Osmolarity in a portable, practical and precise device to collect specimens and analysis all in one. VeriLyte™ Technology integrates specimen collection and analysis all within the ScoutPro pen, the LCD screen displays results in seconds, you can also view prior test results.
Topcon’s MYAH has Dry Eye assessment tools to grow your Dry Eye Practice, it now has new questionnaires that you can report on, the OSDI (Ocular Surface Disease Index) questionnaire comprises of 12 questions, the answers to these questions are used to calculate a score which serves as an indicator of the severity of a patient’s dry eye symptoms. With the incorporation of the questionnaires, we’re now gathering supplementary data to enhance our presentations, the questionnaire data is seamlessly integrated into the relevant report and it enables a comprehensive comparison of metrics from various exams.
The Eye-light® from Espansione Group featuring both core technologies, Light Modulation®/LLLT and Optimal Power Energy®/IPL, for an optimal, non-invasive treatment of most ocular surface conditions. It’s the first approved customised LM®/LLLT treatment for Dry Eye Disease provides quick and easy treatment that gives instant relief from the symptoms of Dry Eye, and in the long term enables management and treatment better than other technology. LLLT Treatment can also be delivered as a standalone treatment with the mgd-mask®.
Find out more HERE
